GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Price-to-Funds-From-Operations

Xintela AB (OSTO:XINT) Price-to-Funds-From-Operations : (As of Jun. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Xintela AB (OSTO:XINT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.